Has good gastrointestinal fluid tolerance and intestinal adhesion ability, can reach the intestines and adhere to intestinal epithelial cells smoothly. Animal experiments show that WKB148 can effectively inhibit pathogenic bacteria such as Shigella flexneri and increase the relative abundance of beneficial bacteria in the intestines of mice.

Resistant to gastric acid and bile, secretes lactic acid, lowers the pH in the intestine, effectively inhibits pathogenic bacteria such as Staphylococcus aureus, Escherichia coli, and Salmonella, helps promote the growth of other probiotic strains, and improves the balance of intestinal flora.

Is resistant to gastric acid and bile, ensuring the viability of strains upon reaching the intestines, while also exhibiting strong adherence to intestinal epithelial cells. It can inhibit common harmful bacterial populations in the intestines, promote the proliferation of probiotics in the human body, and effectively enhance the structure of the intestinal microbiota.

Effectively inhibits Staphylococcus aureus, Escherichia coli and Salmonella, significantly reduces the adhesion of pathogens to HT 29 cells, regulates the abundance of intestinal flora such as Akkermansia, and regulates the body's immunity by affecting cytokine levels.

Can produce abundant short-chain fatty acids. Animal and human trials have consistently shown that LC89 effectively improves inflammatory bowel diseases in hosts, mitigating symptoms including abdominal pain, diarrhea, and decreased appetite induced by these conditions.